Objective To determine the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) in a high-risk aortic stenosis (AS) population.

In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.

A medical patient from Peterborough is among the first to receive a pioneering treatment for heart valve disease.

Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to London. Five people from Cambridgeshire, Essex, Hertfordshire, Peterborough and ...

Yang noted that SAVR and TAVR on their own just put valves in without any change in annular structure. Surgeons often turn ...

Other important pathogenic factors are positive family history and genetic history (connective tissue disease, Ehlers-Danlos syndrome, Marfan syndrome), aortic disease and aortic valve (AV) diseases, ...

The prevalence of aortic stenosis (AS) and amyloid transthyretin cardiomyopathy (ATTR‐CM) increases with age. While the global prevalence of calcific aortic valve disease is estimated to be >2% in ...